Identification of a previously undescribed divergent virus from the Flaviviridae family in an outbreak of equine serum hepatitis

Theiler's disease is an acute hepatitis in horses that is associated with the administration of equine blood products; its etiologic agent has remained unknown for nearly a century. Here, we used massively parallel sequencing to explore samples from a recent Theiler's disease outbreak. Metatranscriptomic analysis of the short sequence reads identified a 10.5-kb sequence from a previously undescribed virus of the Flaviviridae family, which we designate “Theiler's disease-associated virus” (TDAV). Phylogenetic analysis clusters TDAV with GB viruses of the recently proposed Pegivirus genus, although it shares only 35.3% amino acid identity with its closest relative, GB virus D. An epidemiological survey of additional horses from three separate locations supports an association between TDAV infection and acute serum hepatitis. Experimental inoculation of horses with TDAV-positive plasma provides evidence that several weeks of viremia preceded liver injury and that liver disease may not be directly related to the level of viremia. Like hepatitis C virus, the best characterized Flaviviridae species known to cause hepatitis, we find TDAV is capable of efficient parenteral transmission, engendering acute and chronic infections associated with a diversity of clinical presentations ranging from subclinical infection to clinical hepatitis.

[1]  O. Tatebe,et al.  A Technique for High-performance Data Processing of Satellite Observation Data via NICT Science Cloud , 2014 .

[2]  P. Simmonds,et al.  Nonprimate Hepaciviruses in Domestic Horses, United Kingdom , 2012, Emerging infectious diseases.

[3]  C. Rice,et al.  Serology-Enabled Discovery of Genetically Diverse Hepaciviruses in a New Host , 2012, Journal of Virology.

[4]  A. Ido,et al.  Clinical Features of Hepatitis C Virus Carriers With Persistently Normal Alanine Aminotransferase Levels , 2012, Hepatitis monthly.

[5]  M. Alter HCV routes of transmission: what goes around comes around. , 2011, Seminars in liver disease.

[6]  M. Nei,et al.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. , 2011, Molecular biology and evolution.

[7]  Nuno A. Fonseca,et al.  Assemblathon 1: a competitive assessment of de novo short read assembly methods. , 2011, Genome research.

[8]  J. Derisi,et al.  Temporal Analysis of the Honey Bee Microbiome Reveals Four Novel Viruses and Seasonal Prevalence of Known Viruses, Nosema, and Crithidia , 2011, PloS one.

[9]  C. Rice,et al.  Characterization of a canine homolog of hepatitis C virus , 2011, Proceedings of the National Academy of Sciences.

[10]  Jack T. Stapleton,et al.  The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae , 2011, The Journal of general virology.

[11]  Stephen P. Luby,et al.  Identification of GBV-D, a Novel GB-like Flavivirus from Old World Frugivorous Bats (Pteropus giganteus) in Bangladesh , 2010, PLoS pathogens.

[12]  Min Gao,et al.  Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect , 2010, Nature.

[13]  J. N. MacLeod,et al.  Genome Sequence, Comparative Analysis, and Population Genetics of the Domestic Horse , 2009, Science.

[14]  D. Lavanchy,et al.  The global burden of hepatitis C , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[15]  Sheng-Nan Lu,et al.  Is the Cancer of the Liver Italian Program system an adequate weighting for survival of hepatocellular carcinoma? Evaluation of intrascore prognostic value among 36 subgroups , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[16]  M. Alter,et al.  The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002 , 2006, Annals of Internal Medicine.

[17]  J. Arnold,et al.  Hepatitis C Virus Nonstructural Protein 5A (NS5A) Is an RNA-binding Protein* , 2005, Journal of Biological Chemistry.

[18]  P. Sarnow,et al.  Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA , 2005, Science.

[19]  C. Rice,et al.  Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase , 2005, Nature.

[20]  Charles M. Rice,et al.  The NS5A Protein of Hepatitis C Virus Is a Zinc Metalloprotein* , 2004, Journal of Biological Chemistry.

[21]  Mark Harris,et al.  Hepatitis C virus NS5A: tales of a promiscuous protein. , 2004, The Journal of general virology.

[22]  B. Anand,et al.  Assessment of correlation between serum titers of hepatitis C virus and severity of liver disease. , 2004, World journal of gastroenterology.

[23]  E. Herniou,et al.  Ancient Coevolution of Baculoviruses and Their Insect Hosts , 2004, Journal of Virology.

[24]  Robert C. Edgar,et al.  MUSCLE: multiple sequence alignment with high accuracy and high throughput. , 2004, Nucleic acids research.

[25]  R. Bartenschlager,et al.  Mutations in Hepatitis C Virus RNAs Conferring Cell Culture Adaptation , 2001, Journal of Virology.

[26]  E L Murphy,et al.  Prevalence of hepatitis C virus infection in the United States. , 1999, The New England journal of medicine.

[27]  Inda,et al.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. , 1999, The New England journal of medicine.

[28]  H. Field,et al.  Virological and molecular biological investigations into equine herpes virus type 2 (EHV-2) experimental infections. , 1998, Virus research.

[29]  J. M. Calvo Romero,et al.  Gastric adenocarcinoma and kidney transplantation , 1998 .

[30]  A. Magrini,et al.  Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels , 1997, Hepatology.

[31]  R. D. de Man,et al.  Lamivudine resistance inimmunocompetent chronic hepatitis B , 1997 .

[32]  Guglick Ma,et al.  Hepatic disease associated with administration of tetanus antitoxin in eight horses. , 1995 .

[33]  B. Irvine,et al.  At least five related, but distinct, hepatitis C viral genotypes exist. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Esteban,et al.  Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. , 1990, The New England journal of medicine.

[35]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[36]  Terry A. Welch,et al.  A Technique for High-Performance Data Compression , 1984, Computer.

[37]  D. Solnick Construction of an adenovirus-SV40 recombinant producing SV40 T antigen from an adenovirus late promoter , 1981, Cell.

[38]  R. Tjian,et al.  Expression of SV40 T antigen under control of adenovirus promoters , 1981, Cell.

[39]  F. Graham,et al.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5. , 1977, The Journal of general virology.

[40]  Panciera Rj Serum hepatitis in the horse. , 1969 .

[41]  Hjerpe Ca SERUM HEPATITIS IN THE HORSE. , 1964 .

[42]  C. Hahn Merck Veterinary Manual , 2010 .

[43]  G. Carlson,et al.  Serum hepatitis associated with commercial plasma transfusion in horses. , 2005, Journal of veterinary internal medicine.

[44]  J. Emparanza,et al.  [The prevalence of hepatitis C virus infection]. , 1998, Gastroenterologia y hepatologia.

[45]  C. Macallister,et al.  Hepatic disease associated with administration of tetanus antitoxin in eight horses. , 1995, Journal of the American Veterinary Medical Association.

[46]  L. Thomsett Acute hepatic failure in the horse. , 1971, Equine veterinary journal.

[47]  J. Pearson,et al.  Isolation of herpesvirus from equine leukocytes: comparison with equine rhinopneumonitis virus. , 1970, Canadian journal of comparative medicine : Revue canadienne de medecine comparee.

[48]  R. Panciera Serum hepatitis in the horse. , 1969, Journal of the American Veterinary Medical Association.

[49]  A. Theiler Acute Liver-Atrophy and Parenchymatous Hepatitis in Horses. , 1918 .